DAAs
DAAs is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals
Model Towards Elimination of Hepatitis C Infection in Egypt: Feasibility and Effectiveness in 73 Villages
Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis C
Effect of Direct AntiViral Drugs of Chronic HCV on eGFR in Assuit Universiry Hospital
Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)
Clinical Trials (5)
Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals
Model Towards Elimination of Hepatitis C Infection in Egypt: Feasibility and Effectiveness in 73 Villages
Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis C
Effect of Direct AntiViral Drugs of Chronic HCV on eGFR in Assuit Universiry Hospital
Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5